We are live on ! Find out more
FCMT

Founders Capital Management (Texas) Portfolio holdings

AUM $231M
1-Year Est. Return 61.68%
This Fund
S&P 500
This Quarter Est. Return
+7.61%
1 Year Est. Return
+61.68%
3 Year Est. Return
+118.08%
5 Year Est. Return
+149.3%
10 Year Est. Return
AUM
$132M
AUM Growth
+$7.11M
Cap. Flow
-$944K
Cap. Flow %
-0.71%
Top 10 Hldgs %
44.8%
Holding
333
New
9
Increased
45
Reduced
44
Closed
16

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$2.27M
2
COP icon
ConocoPhillips
COP
+$1.18M
3
HAL icon
Halliburton
HAL
+$317K
4
MSFT icon
Microsoft
MSFT
+$307K
5
OXY icon
Occidental Petroleum
OXY
+$193K

Sector Composition

Rank Sector Weight
1 Technology 23.29%
2 Industrials 13.15%
3 Energy 11.77%
4 Healthcare 10.71%
5 Consumer Discretionary 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LQD icon
276
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.8B
$7K 0.01%
55
RRC icon
277
Range Resources
RRC
$8.95B
$7K 0.01%
1,370
SWKS icon
278
Skyworks Solutions
SWKS
$10.6B
$7K 0.01%
60
RTN
279
DELISTED
Raytheon Company
RTN
$7K 0.01%
31
CSS
280
DELISTED
CSS Industries, Inc.
CSS
$7K 0.01%
1,500
AR icon
281
Antero Resources
AR
$10.7B
$6K ﹤0.01%
2,000
DD icon
282
DuPont de Nemours
DD
$19.2B
$6K ﹤0.01%
77
FSK icon
283
FS KKR Capital
FSK
$3.44B
$6K ﹤0.01%
250
IWF icon
284
iShares Russell 1000 Growth ETF
IWF
$128B
$6K ﹤0.01%
144
LNG icon
285
Cheniere Energy
LNG
$52.9B
$6K ﹤0.01%
100
SVC
286
Service Properties Trust
SVC
$1.07B
$6K ﹤0.01%
50
TDW icon
287
Tidewater
TDW
$4.12B
$6K ﹤0.01%
300
DMK
288
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$6K ﹤0.01%
114
+57
+100% +$2.76K
ZYNE
289
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$6K ﹤0.01%
1,000
VWTR
290
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$6K ﹤0.01%
500
BDSI
291
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$6K ﹤0.01%
1,000
DOW icon
292
Dow Inc
DOW
$21.2B
$5K ﹤0.01%
97
EXK
293
Endeavour Silver
EXK
$2.83B
$5K ﹤0.01%
2,000
LUV icon
294
Southwest Airlines
LUV
$23B
$5K ﹤0.01%
100
BCIC
295
BCP Investment Corp
BCIC
$92.9M
$5K ﹤0.01%
+221
New +$4.77K
VOE icon
296
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.2B
$5K ﹤0.01%
46
VSTM icon
297
Verastem
VSTM
$610M
$5K ﹤0.01%
333
DSSI
298
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
$5K ﹤0.01%
294
-294
-50% -$4.39K
ELAN icon
299
Elanco Animal Health
ELAN
$11.1B
$4K ﹤0.01%
148
LCTX icon
300
Lineage Cell Therapeutics
LCTX
$278M
$4K ﹤0.01%
4,970

Similar funds

Founders Capital Management (Texas)'s Q4 2019 Portfolio in Review

As of Q4 2019, Founders Capital Management (Texas) held 333 positions worth $132M, up 5.7% from $125M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Founders Capital Management (Texas)'s Q4 2019 filing shows 9 new, 45 increased, 44 reduced and 16 closed positions. Its largest new stake was CVS Health: 503 shares worth $37K. The largest sale was Amgen, an estimated $2.27M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Industrials and Energy.

  • Founders Capital Management (Texas)'s largest Q4 2019 buy was CVS Health: 503 shares worth $37K.
  • Founders Capital Management (Texas) added most to AbbVie in Q4 2019, an estimated $744K increase.
  • Founders Capital Management (Texas)'s biggest Q4 2019 reduction was Microsoft, cutting an estimated $307K.
  • Founders Capital Management (Texas) fully exited Amgen in Q4 2019, selling an estimated $2.27M.
  • Founders Capital Management (Texas)'s ten largest holdings make up 45% of its $132M portfolio in Q4 2019.
  • Founders Capital Management (Texas) opened 9 new positions and closed 16 in Q4 2019.
  • Founders Capital Management (Texas)'s portfolio value rose 5.7% quarter-over-quarter to $132M.

Based on Founders Capital Management (Texas)'s 13F filing for Q4 2019, filed 24 Jan 2020.